The Gross Margin of ReShape Lifesciences Inc (RSLS) is 63.17%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 63.17% |
| 2023-12-31 | 63.93% |
| 2022-12-31 | 60.50% |
| 2021-12-31 | 61.40% |
| 2020-12-31 | 36.48% |
| 2019-12-31 | 10.06% |
| 2018-12-31 | 40.44% |
| 2017-12-31 | 51.36% |
| 2016-12-31 | 17.11% |
| 2015-12-31 | 38.12% |